Although multiple sclerosis (MS) is considered to be a CD4, Th17-mediated autoimmune
disease, supportive evidence is perhaps circumstantial, often based on animal studies, and …

Epstein–Barr Virus (EBV) contributes to the development of lymphoid and epithelial
malignancies. While EBV's latent phase is more commonly associated with EBV-associated …

Epstein-Barr virus (EBV) is a ubiquitous herpes virus that infects the majority of the
population worldwide. The virus can establish a lifelong latent infection in host B …

Infection is the leading cause of non-relapse mortality after allogeneic haematopoietic cell
transplantation (HCT). This occurs as a result of dysfunction to the host immune system from …

The post‐transplant lymphoproliferative disorders (PTLD s) are a heterogeneous group of
neoplasms that are one of the most serious complications of bone marrow and solid organ …

Latent Epstein-Barr virus (EBV) infection is causally linked to several human cancers. EBV
expresses viral oncogenes that promote cell growth and inhibit the apoptotic response to …

Abstract The International Pediatric Transplant Association convened an expert consensus
conference to assess current evidence and develop recommendations for various aspects of …

Epstein-Barr virus (EBV) is typically acquired asymptomatically in childhood. In contrast,
infection later in life often leads to infectious mononucleosis (IM), a febrile illness …

Although many suspected autoimmune diseases are thought to be T cell-mediated, the
response to therapy indicates that depletion of B cells consistently inhibits disease activity. In …

Therapy for relapsing–remitting multiple sclerosis (MS) has advanced dramatically despite
incomplete understanding of the cause of the condition. Current treatment involves inducing …